The case for reverse engineering ketamine and psychedelics: lessons from translational oncology. A Response to Miller et al. "Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies"
Mol Psychiatry. 2023 Aug;28(8):3164-3166.
doi: 10.1038/s41380-023-02102-2.
Epub 2023 May 12.
1 Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
2 Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA. Rodrigo.machadovieira@uth.tmc.edu.